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The human ventricular cardiomyocyte transient outward K+ current (Ito) mediates the
initial phase of myocyte repolarization and its disruption is implicated in Brugada
Syndrome and heart failure (HF). Human cardiac Ito is generated primarily by two
Kv4.3 splice variants (Kv4.3L and Kv4.3S, diverging only by a C-terminal, S6-proximal,
19-residue stretch unique to Kv4.3L), which are differentially remodeled in HF, but
considered functionally alike at baseline. Kv4.3 is regulated in human heart by β
subunits including KChIP2b and KCNEs, but their effects were previously assumed
to be Kv4.3 isoform-independent. Here, this assumption was tested experimentally
using two-electrode voltage-clamp analysis of human subunits co-expressed in
Xenopus laevis oocytes. Unexpectedly, Kv4.3L-KChIP2b channels exhibited up to 8-fold
lower current augmentation, 40% slower inactivation, and 5 mV-shifted steady-state
inactivation compared to Kv4.3S-KChIP2b. A synthetic peptidemimicking the 19-residue
stretch diminished these differences, reinforcing the importance of this segment in
mediating Kv4.3 regulation by KChIP2b. KCNE subunits induced further functional
divergence, including a 7-fold increase in Kv4.3S-KCNE4-KChIP2b current compared to
Kv4.3L-KCNE4-KChIP2b. The discovery of β-subunit-dependent functional divergence
in human Kv4.3 splice variants suggests a C-terminal signaling hub is crucial to governing
β-subunit effects upon Kv4.3, and demonstrates the potential significance of differential
Kv4.3 gene-splicing and β subunit expression in myocyte physiology and pathobiology.
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INTRODUCTION
Human voltage-gated potassium (Kv) channels are generated by a gene family expressing 40
different α subunits, producing a wide range of current properties and diversity of conductances,
gating kinetics and voltage dependence. Kv channels exist as tetramers that form a functional pore,
and channel function can be diversified in some cases by formation of heteromeric channels bearing
more than one type of α subunit, typically within the same Kv subfamily (Xu et al., 1995). Another
mechanism for amplification of this diversity is splice variation (Vega-Saenz de Miera et al., 1992).
Kv4 subfamily α subunits (Kv4.1, Kv4.2, and Kv4.3), encoded by three genes (KCND1, 2, and 3,
respectively), generate subthreshold-activating Kv currents that are transient because they exhibit
fast inactivation, causing current decay over tens to hundreds of milliseconds (Serôdio et al.,
1994, 1996). Kv4.3 is strongly expressed in human cardiomyocytes and neurons. In neurons, Kv4.3
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contributes to ISA (Serôdio et al., 1994), while in cardiac
myocytes it generates Ito (transient outward current; Dixon
et al., 1996; Johns et al., 1997), important for early myocyte
repolarization to counteract depolarization caused by cation
influx through voltage-gated sodium and calcium channels.
Kv4.1, 2, and 3 exhibit close sequence alignment, except for a
divergent additional exon in Kv4.3, beginning after residue 487,
encoding 19 amino acids within the S6-proximal cytosolic C-
terminus (residues 488–506) and unique to Kv4.3. This additional
exon is commonly spliced such that two Kv4.3 splice variants
exist in human tissues. The short version (Kv4.3S) lacks the 19
residues whereas the long form (Kv4.3L) possesses the additional
19 amino acids but is otherwise identical to Kv4.3S (Ohya et al.,
1997; Kong et al., 1998).
Both forms of Kv4.3 are expressed in human and rat heart
(Ohya et al., 1997; Kong et al., 1998) but their expression levels
are altered differentially in human heart failure (HF), Kv4.3L
expression rising∼33% while that of Kv4.3S falls∼75% (Radicke
et al., 2006). HF has reached epidemic proportions, with a
prevalence of >37.7 million people worldwide, and almost 6
million in the United States alone, half of whomdie within 5 years
of diagnosis. HF occurs when heart muscle becomes so weak
that it cannot adequately pump blood into the aorta to supply
the body with oxygenated blood, resulting in pooling of blood in
the heart. HF risk increases with diabetes, obesity, hypertension
and coronary artery disease, and lifestyle factors including a
sodium- and cholesterol-rich diet, and lack of exercise (Roger,
2013; Mozaffarian et al., 2016; Ziaeian and Fonarow, 2016). HF is
tightly associated with reduced Ito density and Kv4.3 expression
in human and canine ventricular myocytes. A reduction in Ito
alters cardiomyocyte action potential morphology and duration,
particularly the early repolarization and plateau phases, at least
partially by perturbing voltage-gated Ca2+ channel activity
(Beuckelmann et al., 1993; Näbauer et al., 1993; Kääb et al., 1998;
Zicha et al., 2004). Approximately half of individuals with HF
die suddenly, with ventricular tachyarrhythmias being a likely
cause in many cases (Cohn et al., 1986; Stevenson et al., 1993). A
greater understanding of the processes underlying perturbation
in HF of ionic currents, including Ito, known to be associated
with ventricular tachyarrhythmias in other genetic arrhythmia
syndromes, has the potential to lead to therapeutic advances in
reducing morbidity and mortality in HF.
Thus, the prior finding that HF splice-dependently remodels
Kv4.3 in human heart is potentially of high significance.
However, homomeric Kv4.3L and Kv4.3S are functionally
indistinguishable at baseline, in terms of macroscopic current
density, gating kinetics, and voltage dependence. Subtle isoform-
dependent differences arise because Kv4.3L contains a consensus
phosphorylation site in its unique 19-residue stretch. Protein
kinase C (PKC) phosphorylation of threonine 504 within this
site differentially modulates Kv4.3L closed state inactivation,
increasing its magnitude in Kv4.3L, while in Kv4.3S (lacking this
site) PKC reduces closed state inactivation. Aside from this, other
effects of PKC were found to be Kv4.3 isoform-independent,
Abbreviations: HF, heart failure; KChIP, K+ channel interacting protein; Kv
channel, voltage-gated potassium channel; PKC, protein kinase C.
similarly inhibiting peak current and not altering open-state
inactivation or recovery from open-state inactivation (Xie et al.,
2009).
Kv currents are further diversified in vivo by formation of
macromolecular complexes between Kv α subunits and other
proteins that alter their functional characteristics. Many of these
channel-regulating proteins appear to be bona fide channel
components, forming stable, obligate, heteromeric channel
complexes with α subunits in vivo, and are referred to as ancillary
or β subunits (in the case of Kv channel modulators). Two major
classes of Kv channel β subunits expressed in human heart are
the KCNEs and the K+ channel interacting proteins (KChIPs;
Abbott and Goldstein, 1998; An et al., 2000). The KCNEs
(also termed MinK-related peptides, or MiRPs) are single-
transmembrane-domain subunits that co-assemble with Kv α
subunits to dictate fundamental properties including channel
α subunit composition, forward trafficking, endocytosis, ion
selectivity, conductance, gating kinetics, voltage dependence, and
the effects of regulation by other proteins (Abbott, 2015, 2016a,b).
KChIPs are cytosolic proteins that also modulate multiple aspects
of Kv channel biology, including trafficking, current density,
gating kinetics, and voltage dependence (An et al., 2000; Rhodes
et al., 2004).
Kv4 channels are able to co-assemble with KCNE proteins
and with KChIPs, almost certainly at the same time, forming
heteromeric channels with varied gating properties and current
magnitude (Radicke et al., 2006; Liu et al., 2008; Levy et al.,
2010). It is thought that Kv4.3 is regulated in human heart
by KChIP2 (and in particular the dominant cardiac isoform,
KChIP2b) and one or more of the KCNEs (Kuo et al., 2001;
Deschênes and Tomaselli, 2002; Radicke et al., 2006). Indeed,
cardiac arrhythmias including Brugada syndrome have been
associated with increased ventricular Ito arising from gain-of-
function mutations in KCND3 (Giudicessi et al., 2011), but also
in KCNE3 (Delpón et al., 2008) and KCNE5 (Ohno et al., 2011).
Despite a plethora of studies on Kv4.3 regulation by KCNEs and
KChIPs on the one hand, and of the function and expression of
Kv4.3L vs. Kv4.3S on the other hand, a comparison of how the
two Kv4.3 splice variants respond to regulation by β subunits
has been lacking, and this response was assumed to be isoform-
independent (Radicke et al., 2006). Here, it is demonstrated
that KChIP2b and KCNEs unexpectedly introduce a number of
striking differences in baseline function between human Kv4.3L
and Kv4.3S. These data both identify a 19-residue C-terminal
stretch important for Kv4.3 regulation by β subunits, and suggest
the functional and pathophysiological significance of differential
remodeling of Kv4.3 splice variants in HF.
MATERIALS AND METHODS
Xenopus laevis Oocyte Channel cRNA and
Peptide Injections
cRNA transcripts encoding hKv4.2, hKv4.3L, hKv4.3S, and
hKChIP2b were generated by in vitro transcription (T7
polymerase mMessage mMachine kit, Thermo Fisher Scientific)
from cDNA sub-cloned into plasmids (a kind gift of Dr. Steve
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A. N. Goldstein) incorporating Xenopus laevis β-globin 5′ and
3′ UTRs flanking the coding region to enhance translation
and cRNA stability, after vector linearization. Human KCNE
genes 1–5 [for KCNE3 and KCNE4, the recently cloned full-
length “L” versions (Abbott, 2016c) were used] were similarly
transcribed from cDNA templates also incorporating Xenopus
laevis β-globin 5′ and 3′ UTRs. cRNA was quantified by
spectrophotometry. Defolliculated stage V and VI Xenopus laevis
oocytes (Ecocyte Bioscience, Austin, TX) were injected with
one, two or three of the subunit cRNAs as follows: 0.04–5
ng of Kv4.x; 0.5–5 ng of KChIP2b, 5 ng of KCNEx (or 1 ng
in some batches for KCNE5, to minimize oocyte toxicity), as
indicated, per oocyte. Oocytes were incubated at 16◦C in SBB
solution (Ecocyte) containing penicillin and streptomycin, with
daily washing, for 36–48 h prior to two-electrode voltage-clamp
(TEVC) recording. For peptide studies, synthetic 19-mer peptides
corresponding to the Kv4.3L-specific C-terminal 19-residue
stretch (“L peptide”; GLSYLVDDPLLSVRTSTIK; 99.2% pure) or
a scrambled control peptide (VLDRLSLYTLIPSKTGVDS; 98.5%
pure) were commercially synthesized (Peptide 2.0, Chantilly,
VA, USA). Peptides were solubilized to 500 µM in an aqueous
solution containing (in mM) 96 KCl, 2 NaCl, 1 MgCl2, 1 CaCl2,
10 HEPES (pH 7.6), and 50 nl injected into oocytes 30–90 min
before TEVC recording to give an estimated final intracellular
peptide concentration of 25 µM (assuming a mean oocyte
volume of 1 µl).
TEVC
TEVC recording was performed at room temperature with
an OC-725C amplifier (Warner Instruments, Hamden, CT)
and pClamp8 software (Molecular Devices, Sunnyvale, CA), on
Xenopus laevis oocytes placed in a small-volume oocyte bath
(Warner), visualized with a dissection microscope. The TEVC
bath solution was (in mM): 96 NaCl, 4 KCl, 1 MgCl2, 1 CaCl2,
10 HEPES (pH 7.6); bath chemicals were from Sigma. TEVC
pipettes were of 1–3 M resistance when filled with 3 M KCl.
Potassium ion currents were recorded in response to a Voltage
protocol consisting of pulses between−80 and+60mV at 20mV
intervals, from a holding potential of −80 mV, to yield current-
Voltage relationships and for fitting of inactivation kinetics. For
quantification of steady-state inactivation, oocytes were held
at −100 mV and prepulsed to Voltages between −120 and 0
mV followed by a tail pulse to +40 mV. For quantification of
inactivation recovery rates, oocytes were double-pulsed to +40
mV with variable recovery times (10–5000 ms) at −120 mV
between pulses, and the magnitude of the second peak compared
to that of the initial peak for each pair. A generic human
ventricular action potential Voltage protocol was also utilized
for comparing effects of channel subunit expression changes; the
protocol is shown in Figure 9.
TEVC data analysis was performed with Clampfit (Molecular
Devices) and Origin 6.1 (OriginLab Corp., Northampton, MA)
software. Values are stated as mean ± SEM. Steady-state
inactivation plots of fraction of available channels vs. Voltage
were plotted vs. prepulse voltage and fitted with a single
Boltzmann function according to:
g = (A1 − A2)/{1+ exp[(V1/2 − V)/Vs]} + A2 (1)
where g is the normalized tail conductance, A1 is the initial
value at −∞, A2 is the final value at +∞, V1/2 is the
half-maximal voltage of activation, and Vs the slope factor.
Current decay arising from channel inactivation curves was
fitted with a standard (zero-shift) single (where possible) or
double exponential decay function with Chebyshev 4-point
smoothing filter. Inactivation recovery kinetics were fitted from
mean normalized fractional recovery currents to a two-phase
exponential association equation:
y = y0 + A1(1− e
−x/t1 )+ A2(1− e
−x/t2 ) (2)
and for cases in which iterative fitting yielded identical τ-values,
a single exponential fit was reported. Because mean inactivation
recovery curves were fitted to improve fit, these data are
reported as a value with no standard error, but rather a chi-
squared test for goodness of fit. In all other cases, values are
reported with standard error of the mean. Where informative,
currents were compared with one another using student’s t-
test to assess statistical significance (P < 0.05). For consistency,
current magnitudes were always compared between groups at a
membrane potential of +40 mV. If multiple comparisons were
performed, a post-hoc Tukey’s HSD-test was performed following
ANOVA.
RESULTS
KChIP2b Is a More Potent Augmenter of
Kv4.3S vs. Kv4.3L Current
TEVC analysis indicated that KChIP2b, the predominant KChIP
isoform in human cardiac myocytes, augments Kv4.3S activity
at +40 mV several-fold more than that of Kv4.3L, across a
>100-fold range of Kv4.3 cRNA quantity injected per oocyte. At
0.2 ng Kv4.3 cRNA per oocyte, co-injection of 1 ng KChIP2b
augmented Kv4.3S current >8-fold but had negligible effects on
Kv4.3L current magnitude (Figures 1A,B). Similar to hKv4.3S,
hKv4.2 lacks the 19-residue C-terminal portion unique to Kv4.3L
(Figure 1C). Also similar to hKv4.3S, hKv4.2 current at +40 mV
was augmented >4-fold by hKChIP2b, compared to <2-fold for
hKv4.3L (1 ng Kv4.x and 5 ng KChIP2b cRNA injected per oocyte;
Figures 1D–F). Thus, the 19-residue stretch unique to Kv4.3L
impairs Kv4 current augmentation by KChIP2b.
KChIP2b Differentially Regulates
Inactivation of Kv4.3S vs. Kv4.3L
For subsequent experiments, unless otherwise indicated, 1
ng Kv4.3 cRNA per oocyte was injected, with or without
5 ng per oocyte KChIP2b and/or KCNE cRNA, to favor
saturation of channels with β subunits while also generating
large enough currents for accurate analysis. As previously
reported (Po et al., 2001), homomeric Kv4.3L current magnitude
was indistinguishable from that of homomeric Kv4.3S across
the −80 to +60 mV voltage range. In contrast, KChIP2b
augmented Kv4.3S more efficiently than Kv4.3L across the
voltage range tested (Figures 2A,B). Similar to previous reports
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FIGURE 1 | KChIP2b differentially augments Kv4.3L and Kv4.3S current magnitude. (A) Exemplar current traces recorded at +40 mV (voltage protocol inset)
from Xenopus oocytes 36–40 h after injection of 0.2 ng cRNA encoding Kv4.3L or Kv4.3S, with or without 1 ng KChIP2b (n = 14–18). Insets: left, scale bars; right,
Voltage clamp protocol. Zero current level indicated by dashed line. (B) Mean ± SEM peak current magnitude at +40 mV for currents recorded as in (A) but with
0.04–5 ng Kv4.3L or S cRNA, with or without 1 or 5 ng KChIP2b cRNA, injected per oocytes, as indicated (n = 14–37). **P < 0.01 vs. all other groups with similar
quantity of cRNA injected, by ANOVA followed by Tukey’s HSD test. (C) Sequence alignment (Clustal TCoffee) of human Kv4.2, Kv4.3L and Kv4.3S protein sequences
in the S6 to C-terminal region, including the segment missing in Kv4.3s (underlined red). (D) Exemplar current traces recorded at +40 mV (voltage protocol as in panel
A) from Xenopus oocytes 36–40 h after injection of 1 ng cRNA encoding hKv4.2 with or without 5 ng hKChIP2b cRNA (n = 16–18). Scale bar inset. Zero current level
indicated by dashed line. (E) Mean ± SEM peak current magnitude at +40 mV for currents recorded as in (E) (n = 16–18). ***P < 0.0001 between groups.
(F) Comparison of Kv4.x current augmentation by hKChIP2b, analyzed from data in panels B and F (1 ng Kv4.x, 5 ng hKChP2b cRNA; n = 16–37).
(Po et al., 2001), homomeric Kv4.3L and Kv4.3S exhibited
similar inactivation rates (quantified at +40 mV, fitted with a
double exponential relationship; Figure 2C). For both Kv4.3L
and Kv4.3S, co-expression with KChIP2b diminished the slow
component of inactivation but slowed the fast component,
such that current decay was well-described by a single
exponential function. Strikingly, however, Kv4.3L-KChIP2b
current inactivated 40% more slowly than Kv4.3S-KChIP2b
current (Figure 2D). Steady-state inactivation was compared
using a double-pulse protocol to quantify the fraction of available
channels at +40 mV following prepulses to a range of voltages.
Homomeric Kv4.3L and Kv4.3S currents were indistinguishable,
whereas KChIP2b right-shifted the voltage dependence of Kv4.3L
steady-state inactivation +5 mV more than for Kv4.3S. Thus,
despite augmenting Kv4.3L current less efficiently, KChIP2b was
more effective at shifting Kv4.3L inactivation voltage dependence,
compared to that of Kv4.3S (Figure 2E). In contrast, recovery
from inactivation, quantified by a double-pulse protocol of fixed-
voltage pulses with variable interpulse intervals, was similar for
Kv4.3L and Kv4.3S alone, and similarly speeded by KChIP2b
for both isoforms (Figure 2F). Values for curve fits for all
parameters and all subunit combinations tested are given in
Table 1 (steady-state inactivation) and Table 2 (recovery from
inactivation).
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FIGURE 2 | KChIP2b differentially affects Kv4.3L and Kv4.3S inactivation rate and voltage dependence. (A) Exemplar current traces recorded from Xenopus
oocytes 36–48 h after injection of 1 ng cRNA (as indicated) encoding Kv4.3L or Kv4.3S alone (black, n = 13–14) or in addition to 5 ng cRNA encoding KChIP2 (red, n
= 13–31). Insets: right, Voltage clamp protocol; left, scale bars. Zero current level indicated by dashed line. (B) Mean ± SEM peak current/voltage relationship for
currents as in (A); n-values as in (A). (C) Box plots showing individual and mean ± SEM values for fast and slow τ of inactivation, and relative amplitude of the fast
component (double exponential fit), of Kv4.3L vs. Kv4.3S, recorded as in (A). n = 13–14. NS, P > 0.05. (D) Box plots showing individual and mean ± SEM values for
τ of inactivation (single exponential fit) of Kv4.3L vs. Kv4.3S, with KChIP2 co-expression. Currents recorded as in (A); n = 13–14. ***P < 1 × 10−15. (E) Upper,
exemplar current trace recorded using a steady-state inactivation protocol, from Xenopus oocytes 36–48 h after injection of cRNA encoding Kv4.3L (1 ng) and
(Continued)
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FIGURE 2 | Continued
KChIP2 (5 ng). Insets: left, Voltage clamp protocol; right, scale bars. Zero current level indicated by dashed line. Lower, mean ± SEM fraction of available
channels/voltage relationship for Kv4.3L vs. Kv4.3S, with/without KChIP2b; currents recorded as in (E); n = 6–8. (F) Upper, exemplar current trace recorded using an
inactivation recovery protocol, from Xenopus oocytes 48 h after injection of cRNA encoding Kv4.3L (1 ng) and KChIP2 (5 ng). Insets: left and lower right, scale bars;
center, voltage clamp protocol. Zero current level indicated by dashed line. Lower, mean ± SEM fractional recovery from inactivation/recovery time for Kv4.3L vs.
Kv4.3S, with/without KChIP2b; recorded as in protocol above; n = 4–6.
KCNE1 Differentially Regulates
Inactivation of Kv4.3S vs. Kv4.3L
In the absence of KChIP2b, co-expression of KCNE1 did not
differentially affect Kv4.3L vs. Kv4.3S current magnitude; in
contrast, when co-expressed with both KChIP2b and KCNE1,
Kv4.3S current was twice that of Kv4.3L (Figure 3A) as observed
in the absence of KCNE1 (Figures 2A,B). However, KCNE1
slowed Kv4.3S inactivationmore than that of Kv4.3L (Figure 3B).
Kv4.3L-KCNE1-KChIP2b was >40% slower inactivating than
Kv4.3S-KCNE1-KChIP2b (Figure 3C), similar to effects in the
absence of KCNE1 (Figure 2D). Steady-state inactivation in
the absence of KChIP2b could not be compared because
of contamination in this longer protocol by activation of
endogenous oocyte KCNQ1 by KCNE1, but in the presence of
KChIP2 these currents did not noticeably overlap with those
of Kv4.3, which showed a larger positive shift in steady-state
inactivation for Kv4.3L than Kv4.3S, with KCNE1 and KChIP2b
(Figure 3D), as also observed without KCNE1 (Figure 2E).
Recovery from inactivation was slower for Kv4.3S than Kv4.3L
channels co-expressed with KCNE1, but this effect was reversed
by KChIP2b, with recovery being twice as fast for channels
containing Kv4.3S compared to Kv4.3L (Figure 3E).
KCNE2 Preferentially Speeds Inactivation
Recovery of Kv4.3S vs. Kv4.3L
In the absence of KChIP2b, KCNE2 did not differentially affect
Kv4.3L vs. Kv4.3S current magnitude; with KChIP2b and KCNE2,
Kv4.3S current was almost 3-fold that of Kv4.3L (Figure 4A).
KCNE2 similarly converted Kv4.3L and Kv4.3S inactivation
to a single-exponential decay without differentially altering
the rates, but co-expression with KChIP2b left Kv4.3S-KCNE2
inactivation unaffected, while slowing that of Kv4.3l-KCNE2 by
40% (Figure 4B). Steady-state inactivation of Kv4.3 was isoform-
independent with KCNE2, but co-expression of KChIP2 again
shifted voltage dependence by 5 mV more in tripartite channels
formed with Kv4.3L (Figure 4C). KCNE2 preferentially speeded
recovery from inactivation of Kv4.3S vs. Kv4.3L, but only in the
absence of KChIP2b (Figure 4D).
KCNE3 Alleviates Kv4.3
Isoform-Dependence of KChIP2b Effects
on Inactivation
KCNE3 was equally inhibitory to Kv4.3L and Kv4.3S, an
effect alleviated by KChIP2b only for Kv4.3S (increasing
current to 7-fold that in the absence of KChIP2b; Figure 5A).
Regardless of KChIP2b expression, Kv4.3 inactivation rate
and voltage dependence were isoform-independent when co-
expressed with KCNE3 (Figures 5B–D). KCNE3 appeared to
TABLE 1 | Steady-state inactivation parameters.
Subunits V0.5 (mV) Slope (1/mV) R
2
Kv4.3L −61.4 ± 0.34 6.9 ± 0.47 0.998
Kv4.3S −61.4 ± 0.37 5.8 ± 0.27 0.9991
Kv4.3L-KChIP2b −49.0 ± 0.78 4.4 ± 0.34 0.9999
Kv4.3S-KChIP2b −54.0 ± 0.78 4.0 ± 0.36 0.9994
Kv4.3L-KCNE2 −60.6 ± 0.54 6.7 ± 0.49 0.999
Kv4.3L-KCNE3 −60.5 ± 061 6.4 ± 0.40 0.9992
Kv4.3L-KCNE5 −63.3 ± 0.82 7.1 ± 0.44 0.9998
Kv4.3S-KCNE2 −57.9 ± 0.87 6.6 ± 0.44 0.9995
Kv4.3S-KCNE3 −61.4 ± 0.52 5.9 ± 0.39 0.9985
Kv4.3S-KCNE5 −62.2 ± 0.52 6.6 ± 0.31 0.9984
Kv4.3L-KChIP2b-KCNE1 −53.1 ± 0.31 4.5 ± 0.16 0.9997
Kv4.3L-KChIP2b-KCNE2 −53.1 ± 0.2 4.3 ± 0.16 0.9998
Kv4.3L-KChIP2b-KCNE3 −56.4 ± 0.72 4.1 ± 0.3 0.9998
Kv4.3L-KChIP2b-KCNE4 −53.2 ± 0.42 4.5 ± 0.3 0.9998
Kv4.3L-KChIP2b-KCNE5 −49.5 ± 0.77 5.2 ± 0.4 0.9979
Kv4.3S-KChIP2b-KCNE1 −56.9 ± 0.36 4.0 ± 0.22 0.9999
Kv4.3S-KChIP2b-KCNE2 −59.6 ± 0.39 3.5 ± 0.16 0.9999
Kv4.3S-KChIP2b-KCNE3 −54.1 ± 0.27 3.8 ± 0.15 0.9999
Kv4.3S-KChIP2b-KCNE4 −52.9 ± 0.42 4.7 ± 0.2 0.9998
Kv4.3L-Kv4.3S-KChIP2b-KCNE4 −54.6 ± 0.82 3.9 ± 0.36 0.9999
Kv4.3S-KChIP2b-KCNE5 −53.6 ± 1.6 5.2 ± 0.64 0.9999
Fits were made to mean data and therefore P-values are not available for comparisons
between groups, but R2-values are given to indicate goodness of fit. Graphs and n-values
are given in figures and figure legends.
marginally accelerate Kv4.3S-KChIP2 recovery from inactivation
compared to Kv4.3L-KChIP2, but this apparent difference
possibly arose from the large mismatch in current magnitude
between the two subunit combinations (Figure 5E). Low current
magnitudes prevented accurate quantification of recovery in the
absence of KChIP2b.
KCNE4 Kv4.3-Isoform-Dependently
Inhibits Kv4.3-KChIP2b and Accelerates Its
Inactivation and Recovery
KCNE4 potently and similarly inhibited Kv4.3L and Kv4.3S,
while KChIP2b strikingly amplified Kv4.3S-KCNE4 current 25-
fold, compared to only 5-fold for Kv4.3L-KCNE4 (Figure 6A).
Co-injection of 1 + 1 ng Kv4.3L and Kv4.3S with KChIP2b
and KCNE4 (5 + 5 ng) further enhanced peak current, to
∼40-fold that of Kv4.3L or Kv4.3S with KCNE4 in the absence
of KChIP2b (Figure 6A). This was not simply a summation
arising from injecting 2 ng total Kv4.3 cRNA per oocyte, because
increasing cRNA of either Kv4.3 isoform alone to 5 ng did
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TABLE 2 | Inactivation recovery kinetics.
Subunits τfast (ms) Afast τslow (ms) Aslow R
2
Kv4.3L 275 ± 73 0.42 ± 0.13 1066 ± 263 0.45 ± 0.13 0.9999
Kv4.3S 298 ± 63 0.55 ± 0.14 1110 ± 366 0.37 ± 0.14 0.9999
Kv4.3L-KChIP2b 75 ± 4.4 1.07 ± 0.03 n/a n/a 0.9993
Kv4.3S-KChIP2b 74 ± 4.8 1.07 ± 0.04 n/a n/a 0.9994
Kv4.3L-KCNE1 100 ± 55 0.2 ± 0.1 718 ± 151 0.64 ± 0.09 0.9997
Kv4.3L-KCNE2 251 ± 17 0.43 ± 0.03 1038 ± 53 0.50 ± 0.03 0.9999
Kv4.3L-KCNE5 309 ± 21 0.83 ± 0.05 1962 ± 2873 0.06 ± 0.04 0.9996
Kv4.3S-KCNE1 n/a n/a 610 ± 110 0.16 ± 0.01 0.998
Kv4.3S-KCNE2 322 ± 132 0.39 ± 0.45 616 ± 172 0.53 ± 0.46 0.9998
Kv4.3S-KCNE5 361 ± 17 0.72 ± 0.01 n/a n/a 0.9984
Kv4.3L-KChIP2b-KCNE1 117 ± 6.8 1.04 ± 0.04 n/a n/a 0.999
Kv4.3L-KChIP2b-KCNE2 103 ± 3.2 1.21 ± 0.03 n/a n/a 0.9997
Kv4.3L-KChIP2b-KCNE3 103 ± 3.8 1.1 ± 0.03 n/a n/a 0.9995
Kv4.3L-KChIP2b-KCNE4 84.8 ± 2.8 1.14 ± 0.03 n/a n/a 0.9997
Kv4.3L-KChIP2b-KCNE5 73.0 ± 1.65 1.19 ± 0.02 n/a n/a 0.9998
Kv4.3S-KChIP2b-KCNE1 63.7 ± 1.02 1.09 ± 0.01 n/a n/a 0.9997
Kv4.3S-KChIP2b-KCNE2 106 ± 4.0 1.13 ± 0.02 n/a n/a 0.9989
Kv4.3S-KChIP2b-KCNE3 73.6 ± 1.5 1.16 ± 0.02 n/a n/a 0.9998
Kv4.3S-KChIP2b-KCNE4 55.8 ± 1.64 1.32 ± 0.05 n/a n/a 0.9997
Kv4.3L-Kv4.3S-KChIP2b-KCNE4 59.85 ± 0.78 1.12 ± 0.01 n/a n/a 0.9995
Kv4.3S-KChIP2b-KCNE5 67.4 ± 0.88 1.08 ± 0.01 n/a n/a 0.9998
Fits were made to mean data and therefore P-values are not available for comparisons between groups, but R2-values are given to indicate goodness of fit. Graphs and n-values are
given in figures and figure legends; n/a, not applicable (single exponential fit).
not increase current at +40 mV beyond that of 1 ng of
single Kv4.3 isoform-injected oocytes, when co-expressed with
KCNE4 and KChIP2b (Figure 6A inset). Analysis of Kv4.3-
KCNE4 inactivation was hampered by low current magnitude,
but facilitated by KChIP2b co-expression. KCNE4 accelerated
Kv4.3L-KChIP2 and Kv4.3S-KChIP2b inactivation (Figure 6B)
by 20–30% compared to in the absence of KCNE4 (Figure 2D),
preserving the Kv4.3 isoform-dependence, i.e., faster inactivation
of Kv4.3S-KChIP2 compared to Kv4.3L-KChIP2 (Figure 6B).
While Kv4.3 steady-state inactivation was isoform-independent
when co-expressed with KCNE4 and KChIP2b (Figure 6C),
Kv4.3S-based channels recovered from inactivation faster than
Kv4.3L-based complexes and the former also exhibited overshoot
whereas the latter did not (Figure 6D). Interestingly, channels
generated by expression of both Kv4.3L and Kv4.3S together with
KChIP2b and KCNE4 (circles) had similar rates of inactivation
and recovery from inactivation to Kv4.3S-KChIP2b-KCNE4 but
not Kv4.3L-KChIP2b-KCNE4 (Figures 6B,D) while steady-state
inactivation was similar for all three groups (Figure 6C).
KCNE5 Inhibits Kv4.3S More than Kv4.3L
KCNE5 inhibited Kv4.3S activity such that it was ∼3-fold lower
than that of Kv4.3L; KChIP2b effectively amplified Kv4.3S-
KCNE5 current to a level similar to that in the absence of
KCNE5 but only restored Kv4.3L current to half this amount,
similar to that of Kv4.3L alone (Figures 2A,B, 7A). Kv4.3-KCNE5
inactivation rate, voltage dependence and recovery were isoform-
independent without KChIP2b. With KChIP2b and KCNE5
co-expression, there were two isoform-dependent differences:
Kv4.3S inactivation was again faster than that of Kv4.3L, whereas
the steady-state inactivation of the latter had a 4 mV more
positive V0.5 compared to Kv4.3S (Figures 7C–E).
Kv4.3S-KChIP2 Function Is Modified by a
Peptide Corresponding to Kv4.3L Residues
488–506
Functional differences between Kv4.3S and Kv4.3L in the
presence of KChIP2b were partially alleviated by injection,
30–90 min prior to TEVC recording, of a peptide (25 µM)
corresponding to the Kv4.3L-specific C-terminal 19-residue
stretch, residues 488–506 (“L peptide”). As a control, currents
were compared to those of oocytes injected with a sequence-
scrambled 19-mer control peptide. The L peptide reduced
Kv4.3S-KChIP2 currents by 36% (P = 0.02, n = 13–17) but
had no effects on current magnitude of Kv4.3S in the absence
of KChIP2b, nor on Kv4.3L in the absence or presence of
KChIP2b (Figure 8A). The L peptide did not alter homomeric
Kv4.2 current magnitude, but reduced Kv4.2-KChIP2b current
magnitude by 28.5%, although this did not reach statistical
significance (P = 0.13, n = 12–13). In addition, the L
peptide slowed Kv4.3S-KChIP2b inactivation rate 11% (P =
0.03, n = 12–17) but had no statistically significant effects
on the inactivation rate of channels formed from other
subunit combinations (Figure 8B). Note that for simplicity of
comparisons, for peptide experiments inactivation rates were
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FIGURE 3 | KCNE1 differentially affects Kv4.3L and Kv4.3S function with/without KChIP2b. (A) Mean ± SEM peak current/voltage relationship for current
traces recorded from Xenopus oocytes 48 h after injection of cRNA encoding Kv4.3L or Kv4.3S (1 ng) with KCNE1 (5 ng), with or without KChIP2b (5 ng; n = 9–17).
Inset: Voltage clamp protocol. **P < 0.01 compared to other currents at +40 mV. (B) Box plots showing individual and mean ± SEM values for τ of fast and slow
components, and relative amplitude, of fast inactivation (double exponential fit) of Kv4.3L-KCNE1 vs. Kv4.3S-KCNE1 currents recorded as in (A); n = 7–11. *P <
0.05; **P < 0.01; NS, P > 0.05. (C) Box plot showing individual and mean ± SEM values for τ of Kv4.3L-KCNE1-KChIP2b vs. Kv4.3S-KCNE1-KChIP2b inactivation
(single exponential fit) for currents recorded as in (B); n = 8–17. **P < 0.01. (D) Mean ± SEM fraction of available channels/voltage relationship for Kv4.3L-KCNE1-
KChIP2b vs. Kv4.3S-KCNE1-KChIP2b currents; voltage protocol upper right inset; n = 6. (E) Mean ± SEM fractional recovery from inactivation/recovery time for
Kv4.3L-KCNE1 vs. Kv4.3S-KCNE1 with (n = 6) or without (n = 3–4) KChIP2b; voltage protocol upper right inset.
fitted with a single exponential regardless of KChIP2 presence or
absence.
Kv4.3S- and KChIP2-Dependent Current
Reduction with Subunit Ratios Mimicking
Those in Human HF
Lastly, Kv4.3L, Kv4.3S, and KChIP2 cRNAs were injected into
oocytes in ratios corresponding to these previously reported
for normal vs. failing human hearts (Radicke et al., 2006),
and current properties examined. Compared to oocytes injected
with equal amounts (2.5 ng of each) of all three cRNAs (to
approximate the conditions reported for non-failing hearts),
injection instead of 3.5 ng Kv4.3L with 0.5 ng each of
Kv4.3S and KChIP2b (approximating the ratio in HF) reduced
peak current 6-fold at +40 mV (P = 1.5 × 10−6; n =
12–17). Injection of 3.5 ng Kv4.3L with 0.5 ng of Kv4.3S
to mimic reduction in the latter observed in HF, but with
a “normal” amount of KChIP2b (2.5 ng), generated an
intermediate current level (Figure 9A). Thus, reductions in
either Kv4.3S or KChIP2b approximating conditions in HF are
sufficient to diminish total Kv4.3 current levels. Compared to
currents generated by injection of equal amounts of cRNA
for Kv4.3L, Kv4.3S and KChIP2b (2.5 + 2.5 + 2.5 ng), the
HF-mimicking subunit cRNA ratio (3.5 + 0.5 + 0.5 ng)
speeded total Kv4.3 inactivation by 9% (P < 0.05, n = 12–
15) whereas reducing solely the Kv4.3S amount had no effect
(Figure 9B).
Currents elicited by Voltage clamp protocols mimicking the
morphology of a generic human ventricular action potential
showed negligible differences in the kinetics of responses to each
Voltage ramp (Figure 9C). Pulsing of oocytes at a frequency
of 1 Hz using this protocol did not result in diminishment
of current magnitude for any of the subunit combinations
tested, showing that inactivation recovery was not compromised
in a meaningful manner by any of the subunit expression
changes; this result also held in additional studies in which
the depolarizing pulse duration and/or the pulse frequency was
doubled (data not shown). As the oocyte studies are conducted at
room temperature, these ratesmore than cover the gating kinetics
that would be required of Ito channels at body temperature in
vivo. Thus, the paramount Ito manifestation (and source of any
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FIGURE 4 | KCNE2 differentially affects Kv4.3L and Kv4.3S function with/without KChIP2b. (A) Mean ± SEM peak current/voltage relationship for current
traces recorded from Xenopus oocytes 36–48 h after injection of cRNA encoding Kv4.3L or Kv4.3S (1 ng) with KCNE2 (5 ng), with or without KChIP2 (5 ng; n =
14–18). Inset: Voltage clamp protocol. ***P < 0.001 compared to Kv4.3L-KChIP2-KCNE2 at +40 mV. (B) Box plot showing individual and mean ± SEM values for τ of
inactivation (single exponential fit) for currents recorded as in (A); n = 14–18. NS, P > 0.05; ***P < 5 × 10−14. (C) Mean ± SEM fraction of available channels/voltage
relationship for Kv4.3L-KCNE2 vs. Kv4.3S-KCNE2 (upper) and Kv4.3L-KCNE2-KChIP2 vs. Kv4.3S-KCNE2-KChIP2 (lower) currents; voltage protocol upper right
inset; n = 6. (D) Mean ± SEM fractional recovery from inactivation/recovery time for Kv4.3L-KCNE2 vs. Kv4.3S-KCNE2 (upper) and Kv4.3L-KCNE2-KChIP2 vs.
Kv4.3S-KCNE2-KChIP2 (lower) currents; voltage protocol upper inset; n = 5–7.
associated pathology) of the HF-associated changes in subunit
expression in vivo would be predicted to be the considerable
drop in current magnitude in response to rapid depolarization
(Figure 9A), rather than changes in Voltage-dependence or
gating kinetics.
DISCUSSION
Native fast-inactivating Kv currents are generated predominantly
by channels containing Kv1.4, Kv3.3, Kv3.4, or Kv4.x α subunits,
all of which exhibit inherent fast-inactivation apparatus [N-
type inactivation domains, although the mechanistic nuances are
different for Kv4.x α subunits (Bärghaan et al., 2008; Dougherty
et al., 2008; Barghaan and Bähring, 2009)]. In the case of
Kv1 and Kv3 subfamily channels, heteromers of α subunits
containing both N-type (fast-inactivating) and delayed rectifier
(slow, C-type inactivating) α subunits can generate currents with
intermediate inactivation kinetics, proportional to the number
of inactivation domains available to plug the pore after channel
opening. Regulatory subunits, including protein kinases and
KCNEs, may further modify Kv1 and Kv3 channel inactivation
rates, and other factors including voltage dependence, surface
expression, and even α subunit composition itself (Abbott et al.,
2001, 2006; Grunnet et al., 2003; Kanda et al., 2011a,b). Kv4
channels are different in that there are no delayed rectifier α
subunits in the Kv4 subfamily, so the channels they form are
always fast-inactivating. Kv4 channels are, however, subject to
modulation by several classes of regulatory proteins, thought
to occur concurrently in vivo in human cardiac and neuronal
Kv4-based macromolecular complexes. The major new finding
in the present study is that beta subunits unlock previously
unrecognized functional differences in Kv4.3 splice variants
known to be expressed in human heart. This is of mechanistic
importance, and is also potentially relevant to cardiovascular
disease, as it predicts that previously recognized, HF-associated
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FIGURE 5 | KCNE3 differentially affects Kv4.3L and Kv4.3S current magnitude with KChIP2b. (A) Mean ± SEM peak current/voltage relationship for current
traces recorded from Xenopus oocytes 36–48 h after injection of cRNA encoding Kv4.3L or Kv4.3S (1 ng) with KCNE3 (5 ng) with or without KChIP2 (5 ng; n =
11–20). Inset: Voltage clamp protocol. ***P < 0.001 compared to other currents at +40 mV. (B) Box plots showing individual and mean ± SEM values for τ of fast and
slow components, and relative amplitude, of fast inactivation (double exponential fit) of Kv4.3L-KCNE3 vs. Kv4.3S-KCNE3 currents recorded as in (A); n = 10–13.
NS, P > 0.05. (C) Box plot showing individual and mean ± SEM values for τ of Kv4.3L-KCNE3-KChIP2 vs. Kv4.3S-KCNE3-KChIP2 inactivation (single exponential fit)
for currents recorded as in (B); n = 11–15. NS, P > 0.05. (D) Mean ± SEM fraction of available channels/voltage relationship for Kv4.3L-KCNE3 vs. Kv4.3S-KCNE3
with/without KChIP2; voltage protocol upper right inset; n = 5–7. (E) Mean ± SEM fractional recovery from inactivation/recovery time for Kv4.3L-KCNE3-KChIP2 vs.
Kv4.3S-KCNE3-KChIP2; voltage protocol upper inset; n = 4–7.
changes in Ito subunit expression could have a robust functional
impact, reducing Ito density by as much as 50%.
The prior assumption with respect to Kv4.3L and Kv4.3S splice
variants was that their function differed only with respect to
their regulation by PKC, via threonine 504 within the C-terminal
19-residue stretch (Po et al., 2001; Xie et al., 2009). Radicke
and colleagues analyzed the functional effects of KChIP2 and
KCNE subunits on Kv4.3L and also discovered HF-associated
remodeling of Kv4.3 splicing and β subunits, but did not examine
functional effects on Kv4.3S (Radicke et al., 2006). While Kv4.3L
transcript was increased by 33% in HF, Kv4.3S transcript was
decreased by 75%, resulting in a net reduction in total Kv4.3
transcript. KCNE4 was the highest-expressed KCNE subunit (128
fg/ng in normal heart; 75 fg/ng in HF) followed by KCNE2 (6.5
fg/ng in normal heart; 5.3 ng in HF). KCNE1 transcript was
increased from 1.7 to 4.7 fg/ng in HF (Radicke et al., 2006).
Placed into the context of the prior findings for HF-associated
subunit remodeling, the combination of subunit expression
changes observed in the present study would be predicted to have
complex but predominantly inhibitory effects on Ito. KCNE4
(the long variant) was shown here to strongly inhibit Kv4.3L-
KChIP2b current but have much weaker inhibitory effects on
Kv4.3S-KChIP2b. Although KCNE4 expression dropped ∼40%
in human heart failure, it was still the predominant KCNE
subunit. Therefore, if expressed in the same myocytes as Kv4.3
and KChIP2b, KCNE4 would be more inhibitory if the balance
of Kv4.3 isoforms shifted heavily toward Kv4.3L as previously
observed (Radicke et al., 2006). This effect would be even greater
if normal hearts express heteromeric Kv4.3L-Kv4.3S-KChIP2b-
KCNE4, as these generate even larger currents than Kv4.3S-
KChIP2b-KCNE4, and would be predicted to be replaced by
the lesser current-passing Kv4.3L-KChIP2b-KCNE4 (Figure 6).
This inhibitory effect would be further exacerbated by reduced
KChIP2 expression in failing hearts, as KChIP2b protects Kv4.3L
from strong inhibition by KCNE4. Reduced KCNE5 in failing
hearts would be predicted to increase Ito, but this would be
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FIGURE 6 | KCNE4 differentially affects Kv4.3L and Kv4.3S function with KChIP2b. (A) Mean ± SEM peak current/voltage relationship for current traces
recorded from Xenopus oocytes 36–48 h after injection of cRNA encoding Kv4.3L (filled squares) and (circles)/or (open squares) Kv4.3S (1 ng), with KCNE4 (5 ng),
with/without KChIP2 (5 ng; n = 10–17). Lower right inset: Voltage clamp protocol. **P < 0.01 compared to all other currents at +40 mV, by one-way ANOVA with
post-hoc Tukey HSD-test. Upper right inset: no effect on current density of individually increasing Kv4.3L (red columns) or Kv4.3S (open columns) cRNA injected, from
1 to 5 ng per oocyte, when co-injected with KCNE4S and KChIP2b cRNA (n = 11–17). NS = P > 0.05 by one-way ANOVA with post-hoc Tukey HSD-test; all other
group comparisons P < 0.01. (B) Box plot showing individual and mean ± SEM values for τ of inactivation (single exponential fit) for Kv4.3L and / or Kv4.3S
co-expressed with KCNE4 and KChIP2; n = 7–15. ***P < 5 × 10−6 vs. other groups; other comparisons P > 0.05. (C) Mean ± SEM fraction of available
channels/voltage relationship for Kv4.3L and/or Kv4.3S co-expressed with KCNE4 and KChIP2; voltage protocol upper right inset; n = 5–6. (D) Mean ± SEM
fractional recovery from inactivation/recovery time for Kv4.3L and/or Kv4.3S co-expressed with KCNE4 and KChIP2; voltage protocol upper inset; n = 5–6. Arrow,
overshoot following recovery from inactivation.
at least partially mitigated by the relatively stronger inhibitory
effects of KCNE5 on Kv4.3L-KChIP2b channels compared
to Kv4.3S-KChIP2b (Figure 7). Finally, KCNE1 upregulation
in failing heart would be predicted to increase IKs [formed
by KCNQ1 and KCNE1 (Barhanin et al., 1996; Sanguinetti
et al., 1996)] and IKr [formed by hERG and one or more
KCNE subunits, including KCNE1—which augments hERG
current (McDonald et al., 1997)]. However, in the case of
Kv4.3, we found that KCNE1 only augments the activity
of channels comprising Kv4.3S and KChIP2b (Figure 3), so
this would again mitigate augmentation of Ito by increased
KCNE1.
Radicke and colleagues did not compare the effects of
KCNE subunits on Kv4.3L in the absence of KChIP2, because
in CHO cells they did not observe Kv4.3L currents in the
absence of KChIP2 (Radicke et al., 2006). Nor has anyone
reported comparing effects of β subunits on Kv4.3S vs. Kv4.3L,
at least partly because the conserved Kv4 N-terminal was the
acknowledged binding site for KChIPs (Bähring et al., 2001;
Wang, 2008), whereas the Kv4.3L and Kv4.3S isoforms differ only
in their C-termini. However, the C-terminal of closely-related α
subunit Kv4.2 also mediates functional effects of KChIPs (Callsen
et al., 2005; Han et al., 2006). The current work recapitulates
this for Kv4.3 and refines it to the extent that a biologically and
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FIGURE 7 | KCNE5 differentially affects Kv4.3L and Kv4.3S function. (A) Mean ± SEM peak current/voltage relationship for current traces recorded from
Xenopus oocytes 36–48 h after injection of cRNA encoding Kv4.3L or Kv4.3S (1 ng) with KCNE5 (1–5 ng) with/without KChIP2b (5 ng; n = 6–12). *P < 0.05 between
Kv4.3L and Kv4.3S with similar β subunits. Inset: Voltage clamp protocol. (B) Box plots showing individual and mean ± SEM values for τ of fast and slow
components, and relative amplitude, of fast inactivation (double exponential fit) of Kv4.3L-KCNE5 vs. Kv4.3S-KCNE5 currents recorded as in (A); n = 5–7. NS, P >
0.05. (C) Box plot showing individual and mean ± SEM values for τ of inactivation (single exponential fit) for Kv4.3L vs. Kv4.3S co-expressed with KCNE5 and
KChIP2; n = 9–12. ***P < 5 × 10−8. (D) Mean ± SEM fraction of available channels/voltage relationship for Kv4.3L-KCNE5 vs. Kv4.3S-KCNE5 channels with (n =
5–12) or without (n = 5–9) KChIP2; voltage protocol inset. (E) Mean ± SEM fractional recovery from inactivation/recovery time for Kv4.3L-KCNE5 vs. Kv4.3S-KCNE5
channels with (n = 7–8) or without (n = 5–6) KChIP2; voltage protocol inset.
FIGURE 8 | Kv4.3S-KChIP2 function is modified by a peptide corresponding to Kv4.3L residues 488–506. (A) Mean ± SEM peak current at 40 mV for current
traces recorded from Xenopus oocytes 48–72 h after injection of 1.5 ng cRNA each encoding the following: Kv4.2 with (n = 10) or without (n = 7–8) KChIP2; Kv4.3L
with (n = 13–20) or without (n = 8–12) KChIP2; Kv4.3S with (n = 13–17) or without (n = 8) KChIP2, 30–90 min following injection of L peptide (red columns) or control
peptide (open columns; final concentration 25 µM). *P < 0.05; all other same-subunit combination comparisons P > 0.05. (B) Mean ± SEM inactivation τ at 40 mV
for current traces recorded from Xenopus oocytes 48–72 h after injection of cRNAs as in (A). *P < 0.05; all other same-subunit combination comparisons P > 0.05.
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FIGURE 9 | Subunit cRNA ratios mimicking those in human HF Kv4.3S- and KChIP2-dependently reduce current. (A) Mean ± SEM peak current/Voltage
relationship for current traces recorded from Xenopus oocytes 48–72 h after injection of cRNAs as indicated (n = 12–15; ***P < 0.001, ****P < 1 × 10−5 vs. current
magnitude for other groups at +40 mV). Lower right inset: Voltage clamp protocol. (B) Box plot showing individual and mean ± SEM values for τ of inactivation (single
exponential fit) for currents generated as in (A), symbols as in (A) (n = 12–15; *P < 0.05, ****P < 1 × 10−5). (C) Averaged current traces elicited by ventricular action
potential-like Voltage protocol (center) recorded in oocytes expressing channel subunit ratios as in (A), line colors as in (A), scaled to mean current magnitudes as in
(A) (left) or normalized for easier comparison of gating kinetics (right). Each trace is an average of 120–300 raw traces recorded from 4 to 10 cells.
pathophysiologically relevant 19-residue segment in the Kv4.3
membrane-proximal C-terminal is shown to markedly influence
the functional consequences of Kv4.3 co-assembly with two
classes of β subunit.
Only select consequences of KChIP2b regulation of Kv4.3
function were attenuated by the 19-residue segment (current
augmentation and slowing of inactivation), and others were
augmented (larger shift in steady-state inactivation voltage
dependence) or unaffected (equally robust increase in rate
of inactivation recovery; similar shift from double- to single-
exponential current decay kinetics during inactivation). Thus,
the 19 residue segment is not suggested to interfere with Kv4.3-
KChIP2b complex formation, instead selectively modulating
functional consequences of the interaction. The finding here that
a synthetic “L” peptide mimicking the 19-residue segment can
acutely alter the effects of KChIP2 on Kv4.3S, altering current
magnitude and inactivation kinetics to levels intermediate
between those of Kv4.3S and Kv4.3L (Figure 8), strongly supports
the premise that the 19-residue segment is directly involved
in modulating some of the functional effects of KChIP2 on
Kv4.3L. There may also be a reduction of the current augmenting
effects of KChIP2b upon Kv4.2, which also lacks the 19-residue
stretch unique to Kv4.3L, although this did not reach statistical
significance. Effects of the L peptide on the function of Kv4.3S
(and on Kv4.2) in complexes with KChIP2b are most likely to
be via direct interaction with KChIP2, because the L peptide
had no effects on channels in the absence of KChIP2. However,
it is technically also feasible that presence of the L peptide,
or the corresponding segment in the Kv4.3L α subunit, alters
conformation of another domain within Kv4.3 in such a way that
the α subunit responds differently to KChIP2b. Because effects
were observed within 30 min of peptide injection, an alternative
hypothesis, that the 19-residue segment only exerts influence on
Kv4.3-KChIP2 complexes early in biogenesis, or dictates whether
they co-assemble in the first place, is highly unlikely given that the
turnover time of Kv4.3-KChIP2 complexes is much longer [e.g.,
t1/2 of decay in pulse chase studies of 7–9 h (Jiang et al., 2009)].
Results described above, together with the observation here
that cRNA ratios approximating those previously observed in
human HF (Radicke et al., 2006) dramatically reduce total Kv4.3
current (Figure 9), strongly suggests that the relative balance of
Kv4.3L and Kv4.3S is crucial to dictating Ito density and kinetics
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when co-assembled with β subunits known to regulate Kv4.3 in
human heart, and raises the idea that therapeutic targeting to
specifically upregulate Kv4.3S would be more beneficial in terms
of Ito density restoration in HF than blanket Kv4.3 upregulation.
It is important to also recognize limitations of the current
study. Xenopus oocytes were used for channel expression,
partly because their robust nature ensures a large quantity of
recordings can be completed in a short time, facilitating direct
comparison of many different subunit combinations within the
same timeframe and same batch of oocytes. In addition, because
Xenopus oocytes are injected individually with cRNA rather than
transfected en masse with cDNA, one can be more assured that
all the intended subunits are expressed in each, and in the
intended quantities. However, no expression system is perfect,
and Xenopus oocytes may lack some of the factors influencing Ito
current characteristics in human heart, or endogenously express
additional proteins not present in cardiac myocytes (although
this criticism can also be leveled for immortal cell lines derived
from mammals). Indeed, because of this, there are no claims
herein that specific subunit combinations/splice variants better
reflect native Ito than previous reports. Rather, a minimalist
system has been utilized to uncover major, unanticipated Kv4.3
splice isoform-dependent functional differences at baseline. A
comparison of different KChIP2 splice variants was not included
here, and only the recently cloned long forms of KCNE3 and
KCNE4 (Abbott, 2016c) were utilized, in favor of the short
forms. In addition, other subunits that may also regulate Kv4.3
in human heart were not studied here. Thus, the experiments
may fail to replicate other nuances that shape human cardiac Ito.
Neither were effects of Brugada syndrome-linked mutations in
Kv4.3 (KCND3; Giudicessi et al., 2011), KCNE3 (Delpón et al.,
2008) and KCNE5 (Ohno et al., 2011) quantified here in the
context of isoform-specific effects, but it will be interesting to
investigate potential differences in the future. Finally, effects of
protein kinases were considered outside the scope of this study,
but a subject for future work. An interesting contrast between
the Kv4.3 isoform-dependent effects observed here compared
to those previously reported for PKC-derived effects is that
for the latter, Kv4.3L characteristics dominated when the two
isoforms were co-expressed and PKC activated (Po et al., 2001);
in the present study, Kv4.3S characteristics presided (and were
apparently further augmented) when co-expressed with Kv4.3L,
KChIP2b and KCNE4 (Figure 6).
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